BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17517063)

  • 41. Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system.
    Lavie M; Voisset C; Vu-Dac N; Zurawski V; Duverlie G; Wychowski C; Dubuisson J
    Hepatology; 2006 Dec; 44(6):1626-34. PubMed ID: 17133472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mild oxidation of lipoproteins increases their affinity for surfaces covered by heparan sulfate and lipoprotein lipase.
    Makoveichuk E; Lookene A; Olivecrona G
    Biochem Biophys Res Commun; 1998 Nov; 252(3):703-10. PubMed ID: 9837770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact.
    Valli MB; Serafino A; Crema A; Bertolini L; Manzin A; Lanzilli G; Bosman C; Iacovacci S; Giunta S; Ponzetto A; Clementi M; Carloni G
    J Med Virol; 2006 Feb; 78(2):192-201. PubMed ID: 16372297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
    Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B
    PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells.
    Sivaram P; Choi SY; Curtiss LK; Goldberg IJ
    J Biol Chem; 1994 Apr; 269(13):9409-12. PubMed ID: 8144523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.
    Jiang J; Wu X; Tang H; Luo G
    PLoS One; 2013; 8(7):e67982. PubMed ID: 23844141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
    Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.
    Scholtes C; Ramière C; Rainteau D; Perrin-Cocon L; Wolf C; Humbert L; Carreras M; Guironnet-Paquet A; Zoulim F; Bartenschlager R; Lotteau V; André P; Diaz O
    Hepatology; 2012 Jul; 56(1):39-48. PubMed ID: 22290760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.
    Burlone ME; Budkowska A
    J Gen Virol; 2009 May; 90(Pt 5):1055-1070. PubMed ID: 19264629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.
    Westhaus S; Bankwitz D; Ernst S; Rohrmann K; Wappler I; Agné C; Luchtefeld M; Schieffer B; Sarrazin C; Manns MP; Pietschmann T; Ciesek S; von Hahn T
    Hepatology; 2013 May; 57(5):1716-24. PubMed ID: 23212706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein component associated with hepatitis C virus is essential for virus infectivity.
    Shimizu Y; Hishiki T; Ujino S; Sugiyama K; Funami K; Shimotohno K
    Curr Opin Virol; 2011 Jul; 1(1):19-26. PubMed ID: 22440563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus.
    Yamamoto S; Fukuhara T; Ono C; Uemura K; Kawachi Y; Shiokawa M; Mori H; Wada M; Shima R; Okamoto T; Hiraga N; Suzuki R; Chayama K; Wakita T; Matsuura Y
    PLoS Pathog; 2016 May; 12(5):e1005610. PubMed ID: 27152966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans.
    Zheng C; Murdoch SJ; Brunzell JD; Sacks FM
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):891-6. PubMed ID: 16410459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
    Westhaus S; Deest M; Nguyen ATX; Stanke F; Heckl D; Costa R; Schambach A; Manns MP; Berg T; Vondran FWR; Sarrazin C; Ciesek S; von Hahn T
    J Hepatol; 2017 Aug; 67(2):237-245. PubMed ID: 28363797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu.
    Denolly S; Granier C; Fontaine N; Pozzetto B; Bourlet T; Guérin M; Cosset FL
    J Hepatol; 2019 Apr; 70(4):626-638. PubMed ID: 30553840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection of mutant CHO clones resistant to murine gammaherpesvirus 68 infection.
    Jarousse N; Coscoy L
    Virology; 2008 Apr; 373(2):376-86. PubMed ID: 18191980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway.
    Fuki IV; Blanchard N; Jin W; Marchadier DH; Millar JS; Glick JM; Rader DJ
    J Biol Chem; 2003 Sep; 278(36):34331-8. PubMed ID: 12810721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
    Bertaux C; Daelemans D; Meertens L; Cormier EG; Reinus JF; Peumans WJ; Van Damme EJ; Igarashi Y; Oki T; Schols D; Dragic T; Balzarini J
    Virology; 2007 Sep; 366(1):40-50. PubMed ID: 17498767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
    Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
    Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.